COVID-19 vaccine safety concerns result in lower vaccination rates among pregnant individuals in the United States usfca SARSCoV2 COVID19 Vaccine Vaccination Pregnancy
By Dr. Chinta SidharthanSep 15 2022Reviewed by Aimee Molineux In a recent study published in Preventive Medicine Reports, researchers evaluated the factors associated with lower coronavirus disease 2019 vaccination rates among pregnant individuals in the United States .
About the study In the present study, the researchers conducted an online national survey between May and July 2021 to understand the attitudes and beliefs about the COVID-19 vaccine that affect the vaccination rates among individuals who are pregnant or breastfeeding. The final participant list consisted of 2,213 individuals between the ages of 18 and 45, who were pregnant or had pregnancies that ended after December 2020, when the COVID-19 vaccines became available in the U.S.
Results The results of the national survey showed that only 8% of the participants had received one or more doses of the COVID-19 vaccine before their pregnancy, and 47% had taken or were planning to take one or more doses of the vaccine during their pregnancy. Another 27% of the participants planned to delay the vaccine to the end of their pregnancy.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US ChildrenOur multicenter comparison of severe pediatric influenza to severe coronavirus disease 2019 demonstrated similar frequencies of life-threatening complications.
Weiterlesen »
Study finds decline in performance of some COVID-19 home testing kits during omicron periodThe performance of some home testing kits for COVID-19 appears to have declined as the omicron variant emerged, suggests a study published by The BMJ today.
Weiterlesen »
End of Covid-19 pandemic ‘in sight’, says World Health OrganisationCovid-19 infections in the UK have dropped to their lowest level for nearly 11 months
Weiterlesen »
Customized bivalent mRNA COVID boosters protect against BA.5 Omicron variantIn a recent study posted to the bioRxiv* pre-print server, researchers from Washington University School of Medicine, Moderna, Inc, and the U.S. National Institutes of Health tested two bivalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines based on the messenger ribonucleic acid (mRNA) platform.
Weiterlesen »
Mechanism of action of different COVID-19 vaccinesIn a recent study posted to the bioRxiv* preprint server, researchers at the University of Tuebingen and Imperial College London assessed humoral and cellular immune responses elicited by the recombinant adenoviral vector (rAdVV)- and messenger ribonucleic acid (mRNA)-based coronavirus disease 2019 (COVID-19) vaccines.
Weiterlesen »